Background: Optimal patient characterization in heart failure with preserved ejection fraction
(HFpEF) is essential to tailor successful treatment strategies. Cardiac magnetic resonance …

Background—Myocardial extracellular volume (ECV) accumulation is one of the key
pathophysiologic features of heart failure with preserved ejection fraction (HFpEF). Our aims …

Objectives: This study sought to assess the presence and extent of focal and diffuse fibrosis
in heart failure in patients with preserved ejection fraction (HFpEF) compared to …

Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …

Background Increased myocardial fibrosis may play a key role in heart failure with preserved
ejection fraction (HFpEF) pathophysiology. The study aim was to evaluate the presence …

Background: Cardiac magnetic resonance techniques permit quantification of the
myocardial extracellular volume fraction (ECV), representing a surrogate marker of reactive …

Background Myocardial fibrosis (MF) in noninfarcted myocardium may be an interstitial
disease pathway that confers vulnerability to hospitalization for heart failure, death, or both …

Background Left ventricular (LV) diastolic dysfunction is the main cause of heart failure with
preserved ejection fraction (HFpEF), and is characterized by LV stiffness and relaxation …

Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Comprehensive diagnostic criteria, accurate prognostic indicators, and effective treatment
for patients with heart failure and a preserved ejection fraction (HFpEF) represent a critically …